By FP assay, we found a moderate (1.4- to 4.6-fold) gain in fungal selectivity for several of our new oxime analogs in binding Hsp90 in whole-cell extracts prepared from C. albicans (SC5314) compared to HEPG2, a human cancer cell line (Fig. 3b). Here, HSP90AA1 is linked to cancer.